Interleukin-2-induced seborrhoeic dermatitis-like eruption [7]

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 2, 2008, Pages 244-245

  Yamamoto, T ^a   Tsuboi, R ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNACE; RECOMBINANT INTERLEUKIN 2; STEROID; UNCLASSIFIED DRUG;

AGED; CANCER IMMUNOTHERAPY; CASE REPORT; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; EYELID EDEMA; FACE ERYTHEMA; HUMAN; KIDNEY CARCINOMA; LETTER; LOW DRUG DOSE; MALE; PERIORBITAL EDEMA; PRIORITY JOURNAL; PRURITUS; SEBORRHEIC DERMATITIS; SYSTEMIC THERAPY;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; DERMATITIS, SEBORRHEIC; HUMANS; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE;

EID: 38348999252     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02299.x     Document Type: Letter

References (6)

1. Fyfe G, Fisher RI, Rosenberg SA, Sznol M, Parkinson DR, Louie AC. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol 1995; 13: 688-696.
2. Asnis LA, Gaspari AA. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol 1995; 33: 393-410.
3. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004; 18: 13-26.
4. Ran Y, Yoshiike T, Ogawa H. Lipase of Malassezia furfur: Some properties and their relationship to cell growth. J Med Vet Mycol 1993; 3: 77-85.
5. Watanabe S, Kano R, Sato H, Nakamura Y, Hasegawa A. The effect of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 2001; 116: 769-773.
6. Chada S, Ramesh R, Mhashilkar AM. Cytokine- and chemokine-based gene therapy for cancer. Curr Opin Mol Ther 2003; 5: 463-474.